Back

Left ventricular ejection fraction, ventricular remodelling and outcomes after sacubitril - valsartan in a real-life cohort.

9 May 2026 (15:30 - 16:30)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - heart failure with HFrEF (2) Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Mr Francisco Amado Romano Matos

University Hospital Dr Negrin, Las Palmas de Gran Canaria (Spain)

7 More presentations in this session

Presentation thumbnail
Integrating oxygen uptake efficiency slope and right ventricular stroke work index in the assessment of right ventricular function in advanced heart failure with reduced ejection fraction
Doctor D. Kosevic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Favorable effects of sacubitril/valsartan treatment on cardiac autonomic function parameters in patients with heart failure and reduced ejection fraction
Doctor P. Kekovic (Prokuplje, RS)
Abstract Slides
Presentation thumbnail
Patients' experiences of home-based monitoring and standardized titration for heart failure with reduced ejection fraction
Ms K. Odefjord (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
Selective inhibition of microRNA-132 with CDR132L in patients with heart failure with reduced/mildly reduced ejection fraction and left ventricular hypertrophy: the 8282-Reduced trial
Professor J. Bauersachs (Hannover, DE)
Abstract Slides
Presentation thumbnail
Are we meeting the guidelines? : a review on management of heart failure patients in a general hospital in UK
Doctor C. Withana (Colombo, LK) Doctor I. Ahmed (Preston, GB)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - heart failure with HFrEF (2)

The Event

Event poster

Heart Failure 2026

9 May 2026 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Association between initiation of sacubitril/valsartan and improved left ventricular ejection fraction in the real world
30 June 2021
thumbnail
Congress Presentation
Reverse remodelling criteria to predict cardiovascular death in heart failure with reduced or mid-range ejection fraction
30 June 2021
thumbnail
ESC Journals
Right ventricular strain as prognostic marker in patients with heart failure receiving sacubitril/valsartan: a sub-analysis of DISCOVER-ARNI, a multicenter Italian study
29 January 2025
thumbnail
Congress Presentation
Late-gadolinium enhancement on CMR is associated with adverse clinical outcomes and determines remodelling in heart failure patients treated with sacubitril/valsartan: a retrospective study
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources